Search

Your search keyword '"Mineral bone disorder"' showing total 143 results

Search Constraints

Start Over You searched for: Descriptor "Mineral bone disorder" Remove constraint Descriptor: "Mineral bone disorder"
143 results on '"Mineral bone disorder"'

Search Results

1. Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors.

2. Associations of Cognitive Function with Serum Magnesium and Phosphate in Hemodialysis Patients: A Cross-Sectional Analysis of the Osaka Dialysis Complication Study (ODCS).

Catalog

Books, media, physical & digital resources

3. Kidney function and bone mineral density in chronic kidney disease patients.

4. Association of calciprotein particles with serum phosphorus among patients undergoing conventional and extended-hours haemodialysis.

5. Safety of cinacalcet in children and adolescents with chronic kidney disease-mineral bone disorder: systematic review and proportional meta-analysis of case series.

8. Vascular calcification maladaptively participates in acute phosphate homeostasis.

9. Antihypertensive treatment with hydrochlorothiazide-hydralazine combination aggravates medial vascular calcification in CKD rats with mineral bone disorder

10. Association between Albuminuria and Serum Phosphate Levels in Non-Dialysis Stage 3-5 Chronic Kidney Disease Patients

11. Corrigendum: Mineral bone disorder in children with chronic kidney disease: data from the KNOW-Ped CKD (Korean cohort study for outcome in patients with pediatric chronic kidney disease) study

12. The frailty phenotype in hemodialysis patients and its association with biochemical markers of mineral bone disorder, inflammation and nutrition

13. Mineral bone disorder in children with chronic kidney disease: Data from the KNOW-Ped CKD (Korean cohort study for outcome in patients with pediatric chronic kidney disease) study

16. Bisphosphonates and bone mineral density in patients with end-stage kidney disease and renal transplants: A 15-year single-centre experience

17. Prevalence of Mineral Bone Disease in Chronic Kidney Disease Patients using Biochemical Markers

18. Diagnosis and Management of Chronic Kidney Disease-Mineral Bone Disease in Children

19. Routine serum biomarkers, but not dual-energy X-ray absorptiometry, correlate with cortical bone mineral density in children and young adults with chronic kidney disease.

20. Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation.

21. Study of Red Blood Cell Indices and Biochemical Parameters of Mineral Bone Disorders in Hemodialysis Patients.

22. Mineral bone disorders (MBD) in patients on peritoneal dialysis

23. Acid-base disorders and the impact on metabolic bone disease in hemodialysis patients.

24. Clinical factors associated with early and persistent hypocalcaemia after parathyroidectomy in patients on dialysis with severe hyperparathyroidism.

25. Mineral Bone Disorders in Kidney Transplantation.

26. Development of a quantitative systems pharmacology model of chronic kidney disease: metabolic bone disorder.

27. Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project.

28. Prevalence of Mineral Bone Disease in Chronic Kidney Disease Patients using Biochemical Markers.

29. Inhibition of tissue‐nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD‐MBD mouse model.

31. Chronic Kidney Disease-Induced Arterial Media Calcification in Rats Prevented by Tissue Non-Specific Alkaline Phosphatase Substrate Supplementation Rather Than Inhibition of the Enzyme

32. Modeled Daily Ingested, Absorbed and Bound Phosphorus: New Measures of Mineral Balance in Hemodialysis Patients.

33. Sclerostin deficiency modifies the development of CKD-MBD in mice.

34. TRASTORNO MINERAL ÓSEO EN NIÑOS CON ENFERMEDAD RENAL CRÓNICA.

35. Identification of differentially expressed miRNAs associated with chronic kidney disease-mineral bone disorder.

36. Varying Patterns of Biomarkers of Mineral and Bone Metabolism After Kidney Transplantation.

37. Calcium as a cardiovascular toxin in CKD-MBD.

38. Coronary risk score for mineral bone disease in chronic non-diabetic hemodialysis patients: results from a prospective pilot study.

39. Electrolyte and Acid-Base Disorders in Chronic Kidney Disease and End-Stage Kidney Failure.

40. Antihypertensive treatment with hydrochlorothiazide-hydralazine combination aggravates medial vascular calcification in CKD rats with mineral bone disorder.

41. Prevalence of Mineral Bone Disease in Chronic Kidney Disease Patients using Biochemical Markers

42. Effect of long‐term use of unfractionated or low‐molecular‐weight heparin on bone mineral density in maintenance hemodialysis patients

43. The Influence of Parathyroidectomy on Osteoporotic Fractures in Kidney Transplant Recipients: Results from a Retrospective Single-Center Trial

44. Corrigendum: Mineral bone disorder in children with chronic kidney disease: data from the KNOW-Ped CKD (Korean cohort study for outcome in patients with pediatric chronic kidney disease) study.

47. Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS.

48. Gender-Related Differences in Chronic Kidney Disease-Associated Vascular Calcification Risk and Potential Risk Mediators: A Scoping Review

49. Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project

50. Mineral bone disorder in children with chronic kidney disease: Data from the KNOW-Ped CKD (Korean cohort study for outcome in patients with pediatric chronic kidney disease) study.